For some immunoassays, if there are large analyte concentration ranges (such as with ferritin, growth hormone, hCG, PRL, Tg, and the tumour markers PSA, CA199, and CA125), antigen-antibody reactions can lead to an antigen excess, resulting in falsely decreased results and potential misdiagnosis [14]. The gene discussed is PROS1; the disease is neoplasm.